Werewolf Therapeutics, Inc.·4

Jan 9, 9:34 PM ET

Leonard Reid 4

4 · Werewolf Therapeutics, Inc. · Filed Jan 9, 2023

Insider Transaction Report

Form 4
Period: 2023-01-03
Leonard Reid
Chief Operating Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-01-03+93,60093,600 total
    Exercise: $2.05Exp: 2032-12-31Common Stock (93,600 underlying)
Footnotes (1)
  • [F1]The option was granted on January 3, 2023 with a Vesting Commencement Date of January 1, 2023. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2027.

Documents

2 files